SGLT-2 inhibitors and their potential in the treatment of diabetes

Diabetes remains a burgeoning global problem, necessitating ongoing efforts on the part of pharmaceutical and device manufacturers, patients, and society to curb the frightening trends in morbidity and mortality attributable to the malady. Since 1835 when phlorizin was discovered, sodium glucose co-...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenwasser, Rebecca F, Sultan, Senan, Sutton, David, Choksi, Rushab, Epstein, Benjamin J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848644/
https://www.ncbi.nlm.nih.gov/pubmed/24348059
http://dx.doi.org/10.2147/DMSO.S34416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848644/
https://www.ncbi.nlm.nih.gov/pubmed/24348059
http://dx.doi.org/10.2147/DMSO.S34416

Ejemplares similares